|
O.G. Filimonova
Features of the management of a patient with postmenopausal osteoporosis and vitamin D deficiency: a clinical case
|
№12 / 2021
|
|
N.S. Alekseeva
Carbohydrate metabolism disorders and osteoporosis
|
№12 / 2021
|
|
T.V. Tazina (1), T.N. Bebneva (2, 3)
Treatment and prevention of vitamin D deficiency from the perspective of personalized medicine
|
№12 / 2021
|
|
A.F. Verbovoy, Yu.A. Dolgikh, N.I. Verbovaya, T.V. Lomonova
Obesity: an invisible disease
|
№12 / 2021
|
|
M.A. Slovak (1), A.V. Kiyaev (1, 2)
Modern approaches to the determination of etiological forms of congenital hypothyroidism in children
|
№12 / 2021
|
|
A.A. Kondrashov, N.A. Shostak
Bone mineral density and androgenic status in men with rheumatoid arthritis
|
№12 / 2021
|
|
P.B. Shorokhova, V.L. Baranov
Differentiated approach to metformin therapy in newly diagnosed type 2 diabetes mellitus from the perspective of pharmacogenetics
|
№12 / 2021
|
|
A.V. Lisker, A.R. Volkova, M.E. Chernaya, V.S. Mozgunova, M.B. Durdyeva
School of diabetes: new education module on insulin pump for patients with type 1 diabetes mellitus
|
№12 / 2021
|
|
N.A. Chernikova
β-cell dysfunction in type 2 diabetes mellitus: the possibilities of modern antihyperglycemic therapy
|
№12 / 2021
|
|
M.B. Antsiferov (1), O.M. Koteshkova (1), M.S. Novikova (1), N.A. Demidov (2)
Possibilities of dapagliflozin in cardio-reno-metabolic protection in patients with and without type 2 diabetes mellitus
|
№12 / 2021
|
|
D.A. Sychev, O.D. Ostroumova, A.P. Pereverzev, A.I. Kochetkov, M.V. Klepikova, E.Yu. Ebzeeva, V.A. De
Risk factors of drug-induced diseases. Part 2. Comorbid diseases and lifestyle factors
|
№12 / 2021
|
|
N.I. Volkova, S.O. Panenko, A.O. Golubeva
Is non-alcoholic fatty liver disease a consequence of obesity and a predictor of diabetes?
|
№12 / 2021
|
Русский
